Literature DB >> 24268799

Prognostic factors in patients with head and neck squamous cell carcinoma with cN3 neck disease: a retrospective case-control study.

Jae Hoon Jung1, Jong-Lyel Roh2, Jeong Hyun Lee3, Sung-Bae Kim4, Sang-Wook Lee5, Seung-Ho Choi1, Soon Yuhl Nam1, Sang Yoon Kim6.   

Abstract

OBJECTIVE: This study examined prognostic factors in patients with head and neck squamous cell carcinoma with advanced neck disease. STUDY
DESIGN: The records of 191 patients with previously untreated head and neck squamous cell carcinoma and metastatic cervical lymph node (LN) >6 cm (cN, n = 70) and 3.01 to 6 cm (control, n = 121) in the greatest dimension were reviewed. Univariate and multivariate analyses were used to identify factors associated with disease-free survival (DFS) and locoregional control (LRC).
RESULTS: In the cN3 group, independent variables for DFS were age, active drinking, LN size, and extranodal extension (P < .05), and that for LRC was age (P = .025). In the control group, independent variables for DFS were tumor location and differentiation and LN bilaterality (P < .05), and that for LRC was LN bilaterality (P = .011).
CONCLUSIONS: The survival of cN3 patients is affected by host and nodal characteristics including age, drinking, nodal size, and extranodal extension.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24268799     DOI: 10.1016/j.oooo.2013.09.010

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  3 in total

1.  Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.

Authors:  Huaising C Ko; Shuai Chen; Aaron M Wieland; Menggang Yu; Andrew M Baschnagel; Gregory K Hartig; Paul M Harari; Matthew E Witek
Journal:  Head Neck       Date:  2017-07-24       Impact factor: 3.147

2.  Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease.

Authors:  Matthew E Witek; Aaron M Wieland; Shuai Chen; Tabassum A Kennedy; Craig R Hullett; Evan Liang; Gregory K Hartig; Randy J Kimple; Paul M Harari
Journal:  Cancers Head Neck       Date:  2017-11-14

3.  Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer.

Authors:  Wan-Yu Chen; Tseng-Cheng Chen; Shih-Fan Lai; Tony Hsiang-Kuang Liang; Bing-Shen Huang; Chun-Wei Wang
Journal:  PLoS One       Date:  2019-12-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.